New York-based NewYork-Presbyterian has 120 AI initiatives to lessen disease burden in clinical/nonclinical areas. They're developing AI diagnoses, ensuring ethical roll-out, and focusing on reducing disease with AI technology. Goals include increasing AI use, leveraging data and expertise, and employing AI to revolutionize disease diagnosis and treatment.
